JP2016520803A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520803A5
JP2016520803A5 JP2016502475A JP2016502475A JP2016520803A5 JP 2016520803 A5 JP2016520803 A5 JP 2016520803A5 JP 2016502475 A JP2016502475 A JP 2016502475A JP 2016502475 A JP2016502475 A JP 2016502475A JP 2016520803 A5 JP2016520803 A5 JP 2016520803A5
Authority
JP
Japan
Prior art keywords
mirna
cancer
level
subject
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502475A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520803A (ja
JP6554458B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/027541 external-priority patent/WO2014152622A1/en
Publication of JP2016520803A publication Critical patent/JP2016520803A/ja
Publication of JP2016520803A5 publication Critical patent/JP2016520803A5/ja
Application granted granted Critical
Publication of JP6554458B2 publication Critical patent/JP6554458B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502475A 2013-03-15 2014-03-14 診断及び治療のためのエクソソームにおけるｍｉＲＮＡバイオジェネシス Expired - Fee Related JP6554458B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361791301P 2013-03-15 2013-03-15
US61/791,301 2013-03-15
PCT/US2014/027541 WO2014152622A1 (en) 2013-03-15 2014-03-14 Mirna biogenesis in exosomes for diagnosis and therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018108450A Division JP6807351B2 (ja) 2013-03-15 2018-06-06 診断及び治療のためのエクソソームにおけるｍｉＲＮＡバイオジェネシス

Publications (3)

Publication Number Publication Date
JP2016520803A JP2016520803A (ja) 2016-07-14
JP2016520803A5 true JP2016520803A5 (https=) 2017-04-13
JP6554458B2 JP6554458B2 (ja) 2019-07-31

Family

ID=51581257

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016502475A Expired - Fee Related JP6554458B2 (ja) 2013-03-15 2014-03-14 診断及び治療のためのエクソソームにおけるｍｉＲＮＡバイオジェネシス
JP2018108450A Active JP6807351B2 (ja) 2013-03-15 2018-06-06 診断及び治療のためのエクソソームにおけるｍｉＲＮＡバイオジェネシス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018108450A Active JP6807351B2 (ja) 2013-03-15 2018-06-06 診断及び治療のためのエクソソームにおけるｍｉＲＮＡバイオジェネシス

Country Status (15)

Country Link
US (2) US20160024503A1 (https=)
EP (2) EP2971162B1 (https=)
JP (2) JP6554458B2 (https=)
KR (1) KR102183406B1 (https=)
CN (2) CN105264092B (https=)
AU (2) AU2014239309B2 (https=)
BR (1) BR112015023275B1 (https=)
CA (2) CA2905081C (https=)
ES (1) ES2966571T3 (https=)
HK (1) HK1218143A1 (https=)
IL (2) IL241409B (https=)
MX (2) MX373957B (https=)
PT (1) PT3527670T (https=)
RU (2) RU2018101152A (https=)
WO (1) WO2014152622A1 (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016150475A1 (en) * 2015-03-22 2016-09-29 Universite De Liege Circulating micrornas for the diagnosis of breast cancer
CN104774966B (zh) * 2015-05-01 2017-07-28 北京博奥医学检验所有限公司 肺腺癌miRNA标记物
EP3307890A1 (en) 2015-06-10 2018-04-18 Board of Regents, The University of Texas System Use of exosomes for the treatment of disease
CN107151661A (zh) * 2016-03-02 2017-09-12 上海润腾生物科技有限公司 一种人外泌体蛋白、试剂盒及其应用
CN106202984B (zh) * 2016-08-26 2018-09-04 赵毅 一种基于多层复杂网络对肿瘤miRNA标志物的筛选方法
WO2018071806A1 (en) * 2016-10-13 2018-04-19 University Of Louisville Research Foundation, Inc. Exosomal biomarkers for diagnosis and prognosis of cancer and related methods
US11783918B2 (en) 2016-11-30 2023-10-10 Microsoft Technology Licensing, Llc DNA random access storage system via ligation
US10793897B2 (en) * 2017-02-08 2020-10-06 Microsoft Technology Licensing, Llc Primer and payload design for retrieval of stored polynucleotides
CA3083140A1 (en) * 2017-11-30 2019-06-06 Provincial Health Services Authority Methods for evaluating head and neck cancers
EP3775258A4 (en) 2018-03-28 2022-01-26 Board of Regents, The University of Texas System IDENTIFICATION OF EPIGENETIC ALTERATIONS IN DNA ISOLATED FROM EXOSOMES
US11648260B2 (en) 2018-03-29 2023-05-16 Technion Research And Development Foundation Limitted Vesicles comprising a PTEN inhibitor and uses of same
US11364280B2 (en) * 2018-04-17 2022-06-21 Taipei Veterans General Hospital Method for blocking stress-induced tumor progression
CA3098105A1 (en) 2018-04-25 2019-10-31 Toray Industries, Inc. Kit, device, and method for detecting bladder cancer
JP7710849B2 (ja) 2018-10-17 2025-07-22 合同会社Ｈ．Ｕ．グループ中央研究所 細胞外小胞の回収方法
US11766484B2 (en) 2019-01-03 2023-09-26 International Business Machines Corporation Exosome vessels for delivery of molecular cargo
US20220136011A1 (en) 2019-02-08 2022-05-05 Board Of Regents, The University Of Texas System Telomerase-containing exosomes for treatment of diseases associated with aging and age-related organ dysfunction
WO2020163553A1 (en) * 2019-02-08 2020-08-13 Virginia Commonwealth University Mda-7/il-24 for cancer treatment and methods of monitoring same
CN118512469A (zh) * 2019-02-26 2024-08-20 首尔大学校产学协力团 包含末端尿苷酰基转移酶4/7表达调控因子的用于预防或治疗癌症的药学组合物
AU2020299633B2 (en) * 2019-07-02 2026-03-26 Ohio State Innovation Foundation Neurodegenerative disease therapies utilizing the skin-brain axis
US20220275455A1 (en) * 2019-07-08 2022-09-01 Preferred Networks, Inc. Data processing and classification for determining a likelihood score for breast disease
CN110358835A (zh) * 2019-07-26 2019-10-22 泗水县人民医院 生物标志物在胃癌检测、诊断中的应用
KR102212699B1 (ko) * 2019-08-12 2021-02-05 한국원자력의학원 유방암 예방 또는 치료용 조성물
CN110607361A (zh) * 2019-10-08 2019-12-24 南京市儿童医院 miR-431作为靶点在制备促进SP表达的药物中的应用
US20230051797A1 (en) 2019-12-23 2023-02-16 Fujirebio Inc. Method for recovering extracellular vesicle and blood collection vessel
EP3862442A3 (en) * 2020-02-04 2021-10-27 Artemisia S.p.A. Method for the early diagnosis of cancer by means of ddpcr analysis of mirna in liquid biopsy
EP3862441A3 (en) * 2020-02-04 2021-10-27 Artemisia S.p.A. Method for the early diagnosis of cancer by means of ddpcr analysis of mirna and protein markers in liquid biopsy
KR102318328B1 (ko) * 2020-04-13 2021-10-27 고려대학교 산학협력단 Gcc2 단백질을 과발현하는 엑소좀 기반 암 진단 또는 예후 예측용 마커 조성물
US20230227916A1 (en) 2020-04-15 2023-07-20 H.U. Group Research Institute G.K. Method for recovering extracellular vesicle
CN111920961B (zh) * 2020-08-14 2023-09-08 福建医科大学附属协和医院 一种治疗癌症的药物
KR102497196B1 (ko) 2020-09-08 2023-02-07 (주)유로테크 전립선암 진단 점수 계산 방법 및 그 용도
EP4212632A4 (en) * 2020-09-08 2024-07-17 Urotech. Co., Ltd. METHODS FOR CALCULATION OF THE DIAGNOSTIC PROSTATE CANCER SCORE AND USES THEREOF
WO2022102246A1 (ja) * 2020-11-11 2022-05-19 国立研究開発法人物質・材料研究機構 細胞で産生された膜小胞に由来する塩基配列を解析する方法、その装置、及び、そのプログラム
CN112662752B (zh) * 2021-01-18 2022-08-23 中国农业大学 一种诊断用生物标志物的应用
KR102310302B1 (ko) * 2021-02-08 2021-10-06 을지대학교 산학협력단 엑소좀 기반 방광암 진단을 위한 정보 제공 방법
CN112760381B (zh) * 2021-02-08 2022-11-01 复旦大学附属中山医院 一种检测肺腺癌预后的miRNA试剂盒
CN117802235B (zh) * 2022-09-30 2025-08-19 上海思路迪生物医学科技有限公司 血液胞外囊泡miRNA在卵巢癌诊断中的应用
CN116121377A (zh) * 2022-11-01 2023-05-16 山西医科大学 一种食管鳞癌外泌体富含的miRNA作为诊断食管鳞癌的标志物中的应用
CN117778574B (zh) * 2023-12-25 2024-09-03 山东中医药大学 Mir937基因组拷贝数扩增在卵巢癌诊断和/或治疗中的应用
CN118421798B (zh) * 2024-05-22 2025-02-07 南通市海门区人民医院 用于检测结直肠癌相关血清生物标志物、sers传感器及制备方法
EP4667011A1 (en) * 2024-06-17 2025-12-24 Bios-Therapy, Physiological Systems for Health S.p.A. Epigenau/11: a natural matrix with therapeutic activity

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030064949A1 (en) 1998-02-17 2003-04-03 Loretta Nielsen Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
KR100519384B1 (ko) 2002-08-13 2005-10-06 (주)누백스 유전자 이입을 이용한 엑소좀의 제조방법 및 상기 엑소좀의 용도
CN1281279C (zh) * 2004-09-16 2006-10-25 浙江大学 针对表皮生长因子基因的小干扰核糖核酸分子及其用途
CA2676113C (en) * 2007-07-25 2014-07-08 University Of Louisville Research Foundation, Inc. Exosome-associated microrna as a diagnostic marker
EP2610342B1 (en) * 2007-09-14 2016-05-04 The Ohio State University Research Foundation MiRNA Expression in Human Peripheral Blood Microvesicles and uses Thereof
CN106310293A (zh) * 2007-09-27 2017-01-11 免疫疫苗技术有限公司 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
KR101810799B1 (ko) 2008-02-01 2017-12-19 더 제너럴 하스피탈 코포레이션 의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
CN102027129B (zh) * 2008-02-28 2014-03-12 俄亥俄州立大学研究基金会 用于前列腺相关病症的诊断、预后和治疗的基于微rna的方法和组合物
WO2009126563A1 (en) * 2008-04-11 2009-10-15 The University Of North Carolina At Chapel Hill Methods and compositions for the regulation of microrna processing
WO2009147519A1 (en) * 2008-06-06 2009-12-10 Centre National De La Recherche Scientifique - Cnrs- Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna
WO2010056337A2 (en) * 2008-11-12 2010-05-20 Caris Mpi, Inc. Methods and systems of using exosomes for determining phenotypes
JP2013526852A (ja) * 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
WO2011133504A2 (en) 2010-04-20 2011-10-27 University Of Florida Research Foundation, Inc. Nanozymes, methods of making nanozymes, and methods of using nanozymes
US9901600B2 (en) * 2011-03-11 2018-02-27 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
CA2871089A1 (en) * 2011-04-20 2012-10-26 Smith Holdings, Llc Methods and compositions for modulating gene expression using components that self assemble in cells and produce rnai activity
KR20140067001A (ko) * 2011-08-08 2014-06-03 카리스 라이프 사이언스 룩셈부르크 홀딩스, 에스.에이.알.엘. 생물지표 조성물 및 방법
US9777042B2 (en) 2011-12-15 2017-10-03 Morehouse School Of Medicine Method of purifying HIV/SIV Nef from exosomal fusion proteins
US9921223B2 (en) 2013-12-04 2018-03-20 Board Of Regents, The University Of Texas System Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis
HUE059718T2 (hu) * 2016-09-02 2022-12-28 Dicerna Pharmaceuticals Inc 4'-foszfát analógok és azokat tartalmazó oligonukleotidok

Similar Documents

Publication Publication Date Title
JP2016520803A5 (https=)
RU2015144212A (ru) Использование биогенеза микрорнк в экзосомах для диагностики и лечения
Huang et al. miR-582-3p and miR-582-5p suppress prostate cancer metastasis to bone by repressing TGF-β signaling
Teixeira et al. Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients
Lee et al. The long non-coding RNA HOTAIR increases tumour growth and invasion in cervical cancer by targeting the Notch pathway
Cheng et al. MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma
Arantes et al. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol
Li et al. Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression
Kim et al. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer
Ahmad et al. Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis
Kim et al. microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma
Jusufović et al. let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non–small–cell lung cancer
JP2017501694A5 (https=)
Yang et al. tRNALys-derived fragment alleviates cisplatin-induced apoptosis in prostate cancer cells
Czajka et al. Family of microRNA-146 regulates RARβ in papillary thyroid carcinoma
Xu et al. Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer
Yang et al. MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression
De Bruyn et al. Is tissue still the issue? The promise of liquid biopsy in uveal melanoma
Shao et al. Methylation-dependent MCM6 repression induced by LINC00472 inhibits triple-negative breast cancer metastasis by disturbing the MEK/ERK signaling pathway
Caserta et al. Gender differences and miRNAs expression in cancer: implications on prognosis and susceptibility
Zhao et al. MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1 Retraction in/10.3892/ol. 2021.12906
Pires et al. HIF-1α-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasion
Song et al. Molecular modification of metadherin/MTDH impacts the sensitivity of breast cancer to doxorubicin
Sekino et al. Transcribed ultraconserved region Uc. 63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer
Xu et al. miR-494 promotes progression of retinoblastoma via PTEN through PI3K/AKT signaling pathway